The latest brain, head and neck cancer news
CAR NKT cells offer a promising novel immunotherapy for solid tumours
Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer…
Browsing: Neuro-oncology, Head and Neck Cancers
Cancer-killing T cells ‘swarm’ to tumours, attracting others to the fight
When immune system T cells find and recognise a target, they release chemicals to attract…
New drug targeting high-risk children’s cancer is ready for trials
A new drug that has passed safety tests in adults is likely to be effective…
Promising breath-test for cancer
The global quest to use a person’s breath analysis for rapid, inexpensive and accurate early-stage…
Black lives also matter in cancer care
It is not biology, but access to health care that is causing Black Non-Hispanic patients…
Blood marker may reduce cancer burden
Researchers at Flinders University are expanding work on a promising blood test model to help…
Strong, durable responses to selpercatinib in RET-driven medullary thyroid cancer
Selpercatinib (Retevmo), a drug targeted precisely against cancers driven by mutations or alterations in the…
Robotic surgery may improve outcomes in mouth and throat cancer
Robotic surgery for patients with early stage, oropharyngeal squamous cell cancer is associated with improved…
Queensland Brain Cancer Clinical Trial Gives Hope to Patients
Queensland researchers have found that patients who received a cellular immunotherapy for the deadly brain…
Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among…